The Indonesian national vaccine itself is one of the government projects that have been developed by Indonesian researchers who have been promised to be a vaccine or injection made by the nation's children to ward off the Covid-19 pandemic.
 Currently, only two developers have entered the industrial sector, the two institutions are the Eijkman Institute with PT Bio Farma and Airlangga University with PT Biotis Pharmaceutical Indonesia.
 In my opinion, as the government, the development of the red and white vaccine itself has its own pros and cons. As the government, we have to look at the current condition of Indonesia. It is known that the increase in Covid-19 cases in Indonesia is undeniably threatening and dangerous.
 The problem is that Indonesia is currently in a critical period and needs immediate help. Indonesia currently uses vaccines from abroad such as Astra Zeneca, Sinovac, etc.
 This is with the aim that the spread of Covid-19 in Indonesia can be slowed and allow Indonesia to get out of the crisis. This may appear not to support the development of domestic vaccines by the nation's children.
